Biotts is excited to announce our participation in the upcoming RESI Conference in Boston! This event is a prime opportunity to engage with early-stage investors and biotech innovators.
We encourage you to explore potential collaborations and learn about our groundbreaking transdermal drug delivery solutions. Our CEO, Jan Henk Hendriks, will be available for meetings throughout the conference.
To schedule a one-on-one meeting with Jan, please visit the event’s partnering website or reach out to him directly. Don’t miss this chance to connect and discover how Biotts’ transdermal solutions can enhance drug delivery and improve patient outcomes!